Daily Cosmetic Research Analysis
Analyzed 14 papers and selected 3 impactful papers.
Summary
Three impactful studies span regenerative biomaterials, cleft surgery planning, and minimally invasive venous interventions. A cell-laden GelMA/silk-fibroin scaffold accelerated murine wound healing with reduced scarring and hair follicle neogenesis; a retrospective cephalometric study quantified how early and multiple cleft surgeries restrict maxillary growth; and a Japanese initiative established incision-free endovenous laser ablation of tributary veins as a guideline-endorsed option with favorable cosmetic outcomes.
Research Themes
- Regenerative biomaterials enabling scar-reduced, appendage-forming skin repair
- Optimization of cleft surgery timing to preserve craniofacial growth
- Incision-free endovenous laser ablation for tributary varicose veins with cosmetic benefits
Selected Articles
1. Silk fibroin nanofibers-GelMA hydrogel composite loaded with embryonic fibroblasts: A strategy for enhanced wound healing.
A bilayer GelMA/silk-fibroin scaffold delivering mouse embryonic fibroblasts improved mechanical stability, supported cell viability and ECM synthesis, and accelerated healing in murine full-thickness wounds. It reduced pathological scarring and uniquely induced hair follicle neogenesis, suggesting a regenerative path toward functional skin restoration.
Impact: Demonstrates a cell-laden biomaterial that not only accelerates wound closure but also induces hair follicle neogenesis, addressing a major unmet need in scarless, functional skin regeneration.
Clinical Implications: While preclinical, this platform suggests future cell-delivery dressings that reduce scarring and restore skin appendages. It provides a rationale for translational studies using clinically suitable cell sources and regulatory-compliant materials.
Key Findings
- SF nanofibers enhanced GelMA hydrogel compressive strength, water retention, and structural stability.
- MEF-laden GelMA/SF supported high cell viability and boosted proliferation and ECM synthesis in vitro.
- In murine full-thickness wounds, the composite modulated inflammation, enhanced re-epithelialization and angiogenesis, promoted organized collagen deposition, reduced scarring, and induced hair follicle neogenesis.
Methodological Strengths
- Integrated in vitro and in vivo assessments demonstrating biological activity and functional wound outcomes.
- Mechanical and physicochemical characterization linking scaffold properties to cellular performance.
Limitations
- Preclinical murine model limits direct generalizability to humans.
- Use of embryonic fibroblasts may face translational and regulatory constraints compared with autologous adult cells.
Future Directions: Evaluate clinically relevant human cell sources and GMP-compatible materials; validate in large-animal wound models with long-term outcomes, sensory recovery, and appendage function; dissect mechanisms of hair follicle neogenesis.
Synthetic and natural polymer scaffolds have been widely utilized in the design of wound dressings to promote skin tissue regeneration and repair. This study developed an innovative bilayer wound dressing by integrating electrospun silk fibroin (SF) nanofibers into a photo-crosslinkable gelatin methacryloyl (GelMA) hydrogel, creating a GelMA/SF composite scaffold specifically designed as a delivery platform for mouse embryonic fibroblasts (MEFs). The incorporation of SF nanofibers substantially improved the compressive stress, water retention capacity, and structural stability of the hydrogel, thereby providing a more stable and supportive microenvironment for the loaded MEFs. In vitro, the GelMA/SF composite not only supported high cell viability but also significantly enhanced the biological activity of the encapsulated MEFs, facilitating their proliferation and extracellular matrix synthesis. In a full-thickness skin wound model, the MEFs-laden GelMA/SF composite actively accelerated wound healing by effectively modulating inflammation, enhancing re-epithelialization, stimulating angiogenesis, and promoting organized collagen deposition. Moreover, this cell-loaded composite system markedly inhibited pathological scarring and uniquely induced wound-induced hair follicle neogenesis. These findings demonstrate that the GelMA/SF composite serves as a highly effective cell delivery platform, enabling functional skin regeneration with reduced scar formation.
2. First Repair is Best: The Facial Growth Consequences of Revision Cleft Surgeries.
In 106 skeletally mature CLP patients, greater surgical burden—especially procedures performed between ages 0–5—was associated with reduced SNA, ANB, facial convexity, and alveolar length. Each surgery beyond three predicted substantial additional decrements in cephalometric growth parameters, underscoring the need to optimize timing and minimize revisions.
Impact: Quantifies how early and multiple cleft-related surgeries constrain maxillary growth, informing surgical sequencing and counseling to reduce long-term deformity.
Clinical Implications: Prioritize meticulous primary repair and reduce early revisions when feasible; consider growth-preserving protocols and timing to mitigate maxillary hypoplasia risk; integrate findings into multidisciplinary cleft care planning.
Key Findings
- Bilateral CLP had significantly reduced maxillary width compared to unilateral CLP (-2.87 mm, p=0.001).
- More total surgeries correlated with decreased SNA, ANB, and facial convexity (p<0.001).
- Surgeries at ages 0–5 associated with reduced SNA, facial convexity, and alveolar length (p<0.02).
- Each surgery beyond three predicted -1.94° SNA, -0.81° ANB, and -2.82° facial convexity angle; surgical burden did not predict the need for orthognathic surgery.
Methodological Strengths
- Cone-beam CT–based cephalometric analysis provides precise skeletal measurements.
- Use of linear and logistic regression to evaluate predictors and adjust for covariates.
Limitations
- Retrospective single-center design susceptible to selection and information bias.
- Causality cannot be inferred; potential residual confounding and treatment heterogeneity.
Future Directions: Prospective, growth-aware surgical protocols with minimized early revisions; multi-center validation; integrate patient-reported outcomes and long-term craniofacial development metrics.
PURPOSE: Surgical scarring has long been hypothesized to contribute to maxillary hypoplasia in patients with cleft lip and palate (CLP), often leading to a need for orthognathic surgery (OGS). This study aimed to identify clinical and surgical factors associated with maxillary hypoplasia in skeletally mature patients with CLP using cephalometric analysis. METHODS: A retrospective review was performed of CLP patients aged ≥16 years with available cone beam CT scans. Cephalometric measurements were obtained using Mimics software. Patient records were reviewed for cleft morphology, number and type of cleft-related surgeries (ages 0-16), surgical timing, demographics, and history of OGS. Linear and logistic regressions were used to evaluate predictors of maxillary hypoplasia and OGS. RESULTS: Among 106 patients, 47.2% had bilateral CLP and 49.1% underwent OGS. The average number of cleft-related surgeries was 4.28. BCLP patients demonstrated significantly reduced maxillary width compared to UCLP (-2.87 mm, p = 0.001). Increasing total number of surgeries was significantly associated with decreased SNA, ANB, and facial convexity angles (p < 0.001). Surgeries performed between ages 0-5 were significantly associated with decreased SNA, facial convexity angle, and alveolar length (p < 0.02). Linear regression showed that each surgery beyond three predicted a 1.94° reduction in SNA, 0.81° reduction in ANB, and 2.82° reduction in facial convexity angle. Surgical burden was not predictive of OGS. CONCLUSIONS: Greater number of cleft-related surgeries, particularly in early childhood, correlates directly with maxillary growth restriction. These findings highlight the importance of optimizing surgical timing and minimizing additional interventions when feasible.
3. Endovenous laser ablation of tributary varicose veins: A literature review and recent initiatives in Japan.
This narrative review consolidates technical advances and national experience with 1470-nm radial 2-ring slim fiber EVLA for tributary varicose veins, highlighting 100% 1-month occlusion without severe complications in a 400-case multicenter series and endorsement in Japan’s 2025 guidelines. It underscores incision-free delivery via a 16-G needle and favorable cosmetic outcomes.
Impact: Elevates an incision-free EVLA technique for tributary veins from niche to guideline-recognized practice, with potential to improve cosmesis and reduce morbidity compared with stab avulsion.
Clinical Implications: Consider R2SF-based VVA as an alternative to stab avulsion or sclerotherapy for tributaries, particularly for patients prioritizing cosmetic outcomes; establish training and credentialing; monitor for transient induration and track long-term occlusion and recurrence.
Key Findings
- 1470-nm radial 2-ring slim fiber enables uniform EVLA via a 16-G needle without skin incisions.
- Japanese multicenter series (n=400) reported 100% 1-month occlusion and no severe complications.
- Japan’s 2025 guidelines recognized tributary VVA as a third option alongside stab avulsion and sclerotherapy; national training programs support dissemination.
Methodological Strengths
- Synthesizes evidence across 14 publications with inclusion of multicenter clinical experience.
- Places technical data within a guideline and national training implementation context.
Limitations
- Narrative (non-PRISMA) review prone to selection bias; heterogeneous source studies.
- Evidence for durability is short-term; requires long-term and international validation and comparative trials.
Future Directions: Prospective, long-term, and international studies comparing VVA to stab avulsion and sclerotherapy; standardized patient-reported cosmetic outcomes; cost-effectiveness analyses.
BackgroundEndovenous laser ablation (EVLA) has become a standard treatment for saphenous trunk reflux. However, its application to tributary varicose veins-referred to as varicose vein ablation (VVA)-has not been well recognized. Early reports using bare-tip fibers were associated with relatively high rates of postoperative complications, including skin burns and nerve injuries, which limited worldwide acceptance of this approach.MethodsThis narrative review summarizes 14 relevant publications, including a recent Japanese multicenter study and guideline development initiatives. Particular attention is given to the introduction of a 1470-nm radial 2-ring slim fiber (R2SF), its technical characteristics, and nationwide clinical experience in Japan. Educational and certification programs initiated by the Japanese Society of Phlebology are also reviewed.ResultsThe R2SF enables uniform endovenous laser ablation via a 16-G venous needle without skin incisions. A Japanese multicenter study involving 400 cases demonstrated complete vein occlusion at 1 month in all treated veins, with no severe complications. Based on accumulating clinical data, the 2025 Japanese guidelines recognized VVA as the third treatment option alongside stab avulsion and sclerotherapy. The author's experience of over 1700 cases further supports low complication rates and favorable cosmetic outcomes. Transient subdermal induration is relatively common but resolves spontaneously without infection or skin damage.ConclusionsVVA using an R2SF represents a safe, minimally invasive, and incision-free approach for treating tributary varicose veins. The Japanese experience, supported by guideline endorsement and national training systems, suggests that VVA may complement some limitations of stab avulsion. Long-term observation and international validation are necessary.